Behaviors and Mental Disorders

All Conditions

Neoplasms

Skin and Connective Tissue Diseases

Symptoms and General Pathology

Nervous System Diseases

Anxiety Disorders

Breast Neoplasms

Syndrome

Depression

Depressive Disorder

Dyssomnias

Parasomnias

Psychomotor Agitation

Restless Legs Syndrome

Breast Diseases

Skin Diseases

All Drugs and Chemicals

Aromatase Inhibitors

Rebecca RP Pedersini, Principal Investigator

Filippo FR Rodella, Study Coordinator

Rebecca RP Pedersini

Lucia LV Vassalli

Edda ES Simoncini

Rebecca RP Rebecca, Pedersini

Insomnia is common in Breast cancer patients during adjuvant therapy with aromatase inhibitor.

However it is difficult to establish whether it is due to the knowledge of the disease or the treatment administred.

The investigators designed a cohort study in which questionnaires for the assessment of sleep quality (Pittsburgh Sleep Quality Index and Insomnia Severity Index), anxiety (State and Trait Anxiety Inventory), depression (Beck Depression Inventory), for the quality of life in general (Functional Assessment of Cancer Therapy) and for the evaluation of RLS (Restless Legs Syndrome Rating Scale) will be prospectively administered to patients with early breast cancer at baseline and during adjuvant treatment with aromatase inhibitors.

As secondary aims the investigators will also evaluate dietary and lifes' factors, born turn over and BMI.

Impact of Adjuvant Treatment With Aromatase Inhibitor on Sleep Disturbances in Postmenopausal Women With Endocrine Responsive Early Breast Cancer

We use some validated questionnaires to measure this item

We asses participants with levels of vitamin out of range

We use statistic software to asses changes

We use statistic software to asses correlation

Ospedale San Raffaele

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Dr Rebecca Pedersini

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Impact of Adjuvant Treatment With Aromatase Inhibitor on Sleep Disturbances in Postmenopausal Women With Endocrine Responsive Early Breast Cancer	NCT02166281	Endocrine Respo...		18 Years -	Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Impact of Adjuvant Treatment With Aromatase Inhibitor on Sleep Disturbances in Postmenopausal Women With Endocrine Responsive Early Breast Cancer	NCT02166281	Endocrine Respo...		18 Years -	Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Spots Global Cancer Trial Database for endocrine responsive early breast cancer